middle.news
Nanosonics Unleashes Faster trophon3 with FDA Nod, Targets 30,000 US Devices
9:39am on Wednesday 6th of August, 2025 AEST
•
Healthcare
Read Story
Nanosonics Unleashes Faster trophon3 with FDA Nod, Targets 30,000 US Devices
9:39am on Wednesday 6th of August, 2025 AEST
Key Points
FDA clearance obtained for trophon3 and trophon2 Plus in the US
trophon3 offers over 40% faster cycle times and enhanced digital integration
Targets ~30,000 new device opportunities in US hospitals and private practices
Upgrade potential for 10,000 first-generation trophon and 20,000 trophon2 devices globally
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nanosonics (ASX:NAN)
OPEN ARTICLE